Biologics targeting specific cytokine pathways are widely used in the treatment of autoimmune diseases, including but not limited to Th2 cytokines (IL-4, IL-5, and IL-13), Th17 cytokines (IL-6, IL-17, and IL-23), and TNF-α. This evidence concerns the gene IL6 and autoimmune disease.